companydata.dkcompanydata.dk

EUROLYSE IVS: Financial statements 2015

CVR: 36462191

Source: annual report 2015, Danish Business Authority

15/12/2014 – 31/12/2015

EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2015 report amounted to DKK 100. The solvency ratio was 100%.

Equity
DKK 100

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EUROLYSE IVS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Lars Mårten Örjan Andersson joins EUROLYSE IVS as directorApr 20, 2015

As of April 20, 2015, Lars Mårten Örjan Andersson is registered as director of EUROLYSE IVS.

Jan Karlsen steps down as director of EUROLYSE IVSApr 20, 2015

As of April 20, 2015, Jan Karlsen has stepped down as director of EUROLYSE IVS.

CRETECSYS IVS changes name to EUROLYSE IVSApr 20, 2015

On April 20, 2015, the company changed its name from CRETECSYS IVS to EUROLYSE IVS.

About EUROLYSE IVS

EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.

Source: annual report 2024, Danish Business Authority